Addiction Treatment Market
Addiction Treatment Market By Treatment Type (Alcohol, Tobacco/Nicotine, Opioid), By Drug Type (Bupropion, Varenicline, Acamprosate, Others), By Treatment Center (Outpatient, Residential, Inpatient), By Distribution Channel & By Region - Global Market Insights 2022 to 2032
Analysis of Addiction Treatment market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Addiction Treatment Market Outlook (2022 to 2032)
The global Addiction Treatment market was poised to expand at a CAGR of 6.7% during the forecast period. Uptake across commercial settings is expected to grow substantially, generating an opportunity worth US$ 50 Mn over the coming decade.
Smoking products such as water pipes often involve the sharing of mouthpieces and hoses, which facilitates transmission of the novel coronavirus in communal and social settings. Conditions which increase oxygen needs or reduce the ability of the body to use it properly jeopardize patients by making them vulnerable to serious lung infections like pneumonia.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Addiction Treatment from 2017 to 2021 Vs Market Projections for 2022 to 2032
In response to the pandemic, the American Society of Addiction Medicine (ASAM) have convened the Caring for Patients during the COVID-19 Task Force (CPDC). This forum includes a national panel of experts in addiction medicine to produce comprehensive resources tailored to addiction medicine treatment within the context of COVID-19. Simultaneously, leading market players are ensuring basic precautionary measures to contain the spread of the pandemic amongst their employees.
They are also capitalizing on the current scenario to boost production of certain drugs. For instance, Alkermes is in the process of identifying new providers who are currently available to administer injections of their medicines, including appropriate retail pharmacies and clinics.
The company is working in close proximity with healthcare providers, pharmacies and other market players to help navigate new challenges which may arise for patients in accessing their prescribed medications. In addition, the company has also updated its VIVITROL and ARISTADA websites with new information on providers and injection sites.
The increased prevalence of cigarette smoking has boosted the prospects for the tobacco and nicotine addiction treatment market. Moreover, the wider availability of nicotine replacement products and drugs to combat tobacco and nicotine addiction shall also drive market growth.
Examples of such products are Varenicline, Bupropion, and Nortriptyline. The tobacco and nicotine addiction treatment segment is anticipated to capture more than half of the global addiction treatment market, expanding at a CAGR of 6.7%.
Which are Some Prominent Drivers of the Addiction Treatment Market?
Global Addiction Treatment Market to Show Robust Growth, Driven by Rise in Tobacco Consumption
Addiction to various substances has been a major problem across the world. Abuse of substances such as alcohol, marijuana, cocaine, prescription medicine, tobacco, and others inflict debilitating damage to the human body. Out of these, tobacco consumption, mostly in the form of cigarette smoking, is a leading cause of death in the world.
Cigarette smoking has increased the prevalence of lung cancers and cardiovascular diseases. More than 8 million people die annually as a result of tobacco consumption.
Fortunately, governments have recognized this threat and have taken concrete steps to limit the casualties arising out of substance addiction. Awareness about hazards has prompted patients to opt for smoking cessation therapy, which is one of the drivers for the global addiction treatment market. Abuse of prescription drugs and the measures taken by governments to curb the same shall also drive the market’s growth.
Drug Awareness Campaigns to Push the Market Prospects
Drug awareness campaigns and addiction & rehab centers are contributing significantly to the market growth. Furthermore, awareness campaigns and related anticipation programs are highly responsible for incorporating rising patient mindfulness, and support to control substance medication in a few nations. For example, in December 2021, the Indian government sent off the "Medication Free India" crusade and gave bearings for checking chronic drug use in the Indian people.
Moreover, in October 2021, the Centers for Disease Control and Prevention (CDC) sent off four reciprocal training efforts planned to arrive at youthful grown-ups ages 18-34 years targeted at preventing drug overdose deaths. The missions give data about the pervasiveness and risks of fentanyl, the dangers and outcomes of blending drugs, the life-saving force of naloxone, and the significance of decreasing the shame around drug use to help medicine and recuperation. Such drives are expanding and adding to the addiction treatment market's development.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Comparative View of Addiction Treatment Markets
Addiction Treatment Market :
| Attributes | Addiction Treatment Market |
|---|---|
| Growth Factor | he increased prevalence of cigarette smoking has boosted the prospects for the tobacco and nicotine addiction treatment market. Moreover, the wider availability of nicotine replacement products and drugs to combat tobacco and nicotine addiction shall also drive market growth. |
| Opportunity | Governments have recognized this threat and have taken concrete steps to limit the casualties arising out of substance addiction. Awareness about hazards has prompted patients to opt for smoking cessation therapy, which is one of the drivers for the global addiction treatment market. |
Peritoneal Cancer Treatment Market :
| Attributes | Peritoneal Cancer Treatment Market |
|---|---|
| Growth Factor | Rising prevalence of the disease has drawn the attention of pharmaceutical companies operating in the peritoneal cancer treatment market to research and develop effective treatment measures. |
| Opportunity | Growing ovarian as well as peritoneal cancer cases along with government funding, increase in healthcare expenditure, and availability of new drugs and therapies are major factors fuelling growth of the peritoneal cancer treatment market. |
Antibiotic-Associated Diarrhea Treatment Market :
| Attributes | Antibiotic-Associated Diarrhea Treatment Market |
|---|---|
| Growth Factor | The prevalence of antibiotic-associated diarrhea treatment market has increased due to the availability of over the counter drugs which has been attributed to increase the prevalence of Antibiotic-associated diarrhea. |
| Opportunity | The rise in the technology and development of online pharmacies is also making patients opt for self-treatments. The overall Antibiotic-associated diarrhea treatment market is pushed by the increasing demand for growing expenditure on healthcare and patient safety. |
Country-wise Analysis
Will Revenue Growth Keep the Momentum High for the U.S. Addiction Treatment Market?
Increasing Need for Eradicating Tobacco Consumption bolstering demand for Addiction Treatment
The United States is the most attractive region for the expansion of the addiction treatment market. Rising adoption of addiction treatment products, particularly for eradicating tobacco consumption and an established healthcare infrastructure are set to boost market prospects. The region is anticipated to hold over two-fifths of the global addiction treatment market, expanding 1.4x during the forecast period.
The United States is supposed to rule the market because of the rising abuse of tobacco and a rising number of government drives pointed toward diminishing substance misuse.
For example, according to a December 2020 update by the Centers for Disease Control and Prevention (CDC), almost 14 out of every 100 United States grown-ups matured 18 years, or more seasoned (14.0%) smoked cigarettes in 2019. According to a similar source, an expected 34.1 million adults in the U.S are presently smoking cigarettes, and around 16 Mn people live with smoking-related ailments and associated ill effects.
Why is India a Prominent Market for Addiction Treatment?
Positively Growing Economy to Push Demand for Addiction Treatment
India is anticipated to expand the fastest, at a robust CAGR of 7.9% during the forecast period. This is because governments in these countries are taking several initiatives to address issues related to drug addiction. For example, in 2021, Sahyog Clinic sent off its new host of medicines like de-enslavement from liquor and medications, restoration, and detoxification from liquor and medications, and that's only the tip of the iceberg. These new arrangements of restoration and different projects would uphold the Government of Delhi's drive to lessen the interest in liquor and medication in the country.
Also, initiatives such as the establishment of smoke-free cities in countries like China are also projected to drive the growth of the addiction treatment market.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Which Distribution Channel is Projected to Boost the Market?
Hospital Pharmacies to Add to the Overall Demand
Based on the distribution channels, the hospital pharmacies are proven as one of the most effective and easily approachable centers for purchasing addiction medication at the primary or initial level. Moreover, Various kinds of medicines are available with different dose levels to calm the subject and decrease the urge for substance abuse. Almost all kinds of prescribed and non-prescribed medicines can be easily available for addicted patients.
Start-Ups For Addiction Treatment Market
Some key startups in the Addiction Treatment market include-
- Canadian startup zpharm offers Cravv, a natural health product for smoking cessation. The startup’s novel medication uses cytisine as a replacement for nicotine addiction. Cytisine aids cessation by reducing the severity of withdrawal and also the satisfaction associated with tobacco use. Moreover, cytisine-based tobacco addiction management offers a more affordable solution, which potentially benefits lower-income countries where most smokers live.
- The US-based startup PursueCare provides at-home telehealth treatment for opioid addiction. The startup combines telehealth technology with traditional medication treatment and counseling to help ensure a successful recovery. The mobile application allows users to explore medication-assisted treatment, addiction counseling, mental health therapy, toxicology screening, care coordination, and medication delivery. Users also have access to an addiction counselor who understands their story and virtually meets with you at any time.
Market Competition
The global Addiction Treatment market is highly competitive owing to the top global players trying to gain market share through various strategies such as mergers & acquisitions, expansions, collaborations, and partnerships. Key players in the global addiction treatment market are engaged in regulatory approvals, and launch of new products.
- In June 2021, AELIS FARMA, a biotechnology organization working in the ailment of cerebrum issues, declared essential cooperation and choice permit concurrence with INDIVIOR PLC to address the serious results of weed use problems (CUD), including marijuana prompted psychosis (CIP).
- In June 2021, Terveystalo Healthcare has procured 72% of shareholding in Feelgood Svenska AB and unveils a suggested required deal of SEK 5.7/share.
Report Scope
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 6.7% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2017 to 2021 |
| Forecast Period | 2022 to 2032 |
| Segments Covered | Treatment Type, Drug Type, Treatment Centers, Distribution Channels, Regions |
| Key Companies Profiled | Alkermes plc; Cipla Ltd.; GlaxoSmithKline plc; Pfizer, Inc.; Mallinckrodt; Hikma Pharmaceuticals PLC; Orexo AB; Titan Pharmaceuticals, Inc.; Teva Pharmaceutical Industries Ltd; Indivor Plc. |
Key Segments Profiled in the Addiction Treatment Industry Survey
Fact.MR has studied the global addiction treatment market with detailed segmentation on the basis of treatment type, drug type, treatment centers, distribution channel, and key regions.
-
By Treatment Type :
- Alcohol
- Tobacco/Nicotine
- Opioid
- Other Substances
-
By Drug Type :
- Bupropion
- Varenicline
- Acamprosate
- Disulfiram
- Naltrexone
- Methadone
- Buprenorphine
- Nicotine Replacement Products
- Others
-
By Treatment Centers :
- Outpatient Treatment Centers
- Residential Treatment Centers
- Inpatient Treatment Centers
-
By Distribution Channel :
- Hospital Pharmacy
- Medical Stores
- Others
-
By Key Regions :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Table of Content
- 1. Preface
- 2. Assumptions and Research Methodology
- 3. Executive Summary: Global Market
- 4. Market Overview
- 5. Global Market Analysis and Forecasts, By Treatment Type
- 5.1. Alcohol Addiction Treatment
- 5.2. Tobacco/Nicotine Addiction Treatment
- 5.3. Opioid Addiction Treatment
- 5.4. Other Substance Addiction Treatment
- 6. Global Market Analysis and Forecasts, By Drug Type
- 6.1. Bupropion
- 6.2. Varenicline
- 6.3. Acamprosate
- 6.4. Disulfiram
- 6.5. Naltrexone
- 6.6. Methadone
- 6.7. Buprenorphine
- 6.8. Nicotine Replacement Products
- 6.9. Others
- 7. Global Market Analysis and Forecasts, By Treatment Centers
- 7.1. Outpatient Treatment Centers
- 7.2. Rehabilitation Treatment Centers
- 7.3. Inpatient Treatment Centers
- 8. Global Market Analysis and Forecasts, By Distribution Channels
- 8.1. Hospital Pharmacy
- 8.2. Medical Stores
- 8.3. Others
- 9. Global Market Analysis and Forecasts, By Geography/Region
- 9.1. North America
- 9.2. Europe
- 9.3. Asia Pacific
- 9.4. Latin America
- 9.5. Middle East & Africa
- 10. North America Market Analysis and Forecast
- 11. Europe Market Analysis and Forecast
- 12. Asia Pacific Market Analysis and Forecast
- 13. Latin America Market Analysis and Forecast
- 14. Middle East & Africa Market Analysis and Forecast
- 15. Competition Landscape
- 15.1. Alkermes plc
- 15.2. Allergan plc
- 15.3. Cipla Ltd.
- 15.4. GlaxoSmithKline plc
- 15.5. Pfizer Inc.
- 15.6. Mallinckrodt Plc.
- 15.7. Purdue Pharma L.P.
- 15.8. Hikma Pharmaceuticals plc
- 15.9. Orexo AB
- 15.10. Reckitt Benckiser (Indivior PLC)
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Size (US$ Mn) and Forecast, by Treatment Type, 2022 to 2032
Table 02: Global Market Size (US$ Mn) Forecast, by Drug Type, 2022 to 2032
Table 03: Global Market Size (US$ Mn) and Forecast, by Treatment Center, 2022 to 2032
Table 04: Global Market Size (US$ Mn) Forecast, by Distribution Channels, 2022 to 2032
Table 05: Global Market Size (US$ Mn) Forecast, by Region, 2022 to 2032
Table 06: North America Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 07: North America Market Size (US$ Mn) Forecast, by Product Type, 2022 to 2032
Table 08: North America Market Size (US$ Mn) Forecast, by Drug Type, 2022 to 2032
Table 09: North America Market Size (US$ Mn) Forecast, by Treatment Centers, 2022 to 2032
Table 10: North America Market Size (US$ Mn) Forecast, by Distribution Channels, 2022 to 2032
Table 11: Europe Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 12: Europe Market Size (US$ Mn) Forecast, by Product Type, 2022 to 2032
Table 13: Europe Market Size (US$ Mn) Forecast, by Drug Type, 2022 to 2032
Table 14: Europe Market Size (US$ Mn) Forecast, by Treatment Centers, 2022 to 2032
Table 15: Europe Market Size (US$ Mn) Forecast, by Distribution Channels, 2022 to 2032
Table 16: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 17: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2022 to 2032
Table 18: Asia Pacific Market Size (US$ Mn) Forecast, by Drug Type, 2022 to 2032
Table 19: Asia Pacific Market Size (US$ Mn) Forecast, by Treatment Centers, 2022 to 2032
Table 20: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channels, 2022 to 2032
Table 21: Latin America Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 22: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2022 to 2032
Table 23: Latin America Market Size (US$ Mn) Forecast, by Drug Type, 2022 to 2032
Table 24: Latin America Market Size (US$ Mn) Forecast, by Treatment Centers, 2022 to 2032
Table 25: Latin America Market Size (US$ Mn) Forecast, by Distribution Channels, 2022 to 2032
Table 26: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2022 to 2032
Table 27: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2022 to 2032
Table 28: Middle East & Africa Market Size (US$ Mn) Forecast, by Drug Type, 2022 to 2032
Table 29: Middle East & Africa Market Size (US$ Mn) Forecast, by Treatment Centers, 2022 to 2032
Table 30: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channels, 2022 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Size (US$ Mn) Forecast, 2022 to 2032
Figure 02: Global Y-o-Y Growth Rate (%), 2022 to 2032
Figure 03: Global Market Value Share, by Region (2018)
Figure 04: Global Market Value Share, by Drug Type (2018)
Figure 05: Global Market Value Share, by Treatment Type (2018)
Figure 06: Global Market Value Share, by Treatment Centers (2018)
Figure 07: Global Market Value Share, by Treatment Type, 2022 and 2032
Figure 08: Global Market Attractiveness, by Treatment Type, 2022 to 2032
Figure 09: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Alcohol Addiction Treatment, 2022 to 2032
Figure 10: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Tobacco/Nicotine Addiction Treatment, 2022 to 2032
Figure 11: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Opioid Addiction, Treatment, 2022 to 2032
Figure 12: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), by Other Substances Addiction Treatment, 2022 to 2032
Figure 13: Global Market Value Share, by Drug Type, 2022 and 2032
Figure 14: Global Market Attractiveness Analysis, by Drug Type, 2022 to 2032
Figure 15: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Bupropion, 2022 to 2032
Figure 16: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Varenicline, 2022 to 2032
Figure 17: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Acamprosate, 2022 to 2032
Figure 18: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Disulfiram, 2022 to 2032
Figure 19: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Naltrexone, 2022 to 2032
Figure 20: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Methadone, 2022 to 2032
Figure 21: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Buprenorphine, 2022 to 2032
Figure 22: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NRT Products, 2022 to 2032
Figure 23: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2022 to 2032
Figure 24: Global Market Value Share, by Treatment Centers, 2022 and 2032
Figure 25: Global Market Attractiveness Analysis, by Treatment Centers, 2022 to 2032
Figure 26: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Outpatient Treatment Centers, 2022 to 2032
Figure 27: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Residential Treatment Centers, 2022 to 2032
Figure 28: Global Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Inpatient Treatment Centers, 2022 to 2032
Figure 29: Global Market Value Share, by Distribution Channels, 2022 and 2032
Figure 30: Global Market Attractiveness Analysis, by Distribution Channels, 2022 to 2032
Figure 31: Global Market Value Share, by Region, 2022 and 2032
Figure 32: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022 to 2032
Figure 33: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022 to 2032
Figure 34: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022 to 2032
Figure 35: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022 to 2032
Figure 36: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022 to 2032
Figure 37: Global Physiotherapy Device Market Attractiveness Analysis, by Region, 2022 to 2032
Figure 38: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022 to 2032
Figure 39: North America Market Value Share, by Country, 2022 and 2032
Figure 40: North America Market Attractiveness, by Country, 2022 to 2032
Figure 41: North America Market Value Share, by Treatment Type, 2022 and 2032
Figure 42: North America Market Attractiveness, by Treatment Type, 2022 to 2032
Figure 43: North America Market Value Share, by Drug Type, 2022 and 2032
Figure 44: North America Market Attractiveness Analysis, by Drug Type, 2022 to 2032
Figure 45: North America Market Value Share, by Treatment Centers, 2022 and 2032
Figure 46: North America Market Attractiveness Analysis, by Treatment Centers, 2022 to 2032
Figure 47: North America Market Value Share, by Distribution Channels, 2022 and 2032
Figure 48: North America Market Attractiveness Analysis, by Distribution Channels, 2022 to 2032
Figure 49: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022 to 2032
Figure 50: Europe Market Value Share, by Country, 2022 and 2032
Figure 51: Europe Market Attractiveness, by Country, 2022 to 2032
Figure 52: Europe Market Value Share, by Treatment Type, 2022 and 2032
Figure 53: Europe Market Attractiveness, by Treatment Type, 2022 to 2032
Figure 54: Europe Market Value Share, by Drug Type, 2022 and 2032
Figure 55: Europe Market Attractiveness Analysis, by Drug Type, 2022 to 2032
Figure 56: Europe Market Value Share, by Treatment Centers, 2022 and 2032
Figure 57: Europe Market Attractiveness Analysis, by Treatment Centers, 2022 to 2032
Figure 58: Europe Market Value Share, by Distribution Channels, 2022 and 2032
Figure 59: Europe Market Attractiveness Analysis, by Distribution Channels, 2022 to 2032
Figure 60: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022 to 2032
Figure 61: Asia Pacific Market Value Share, by Country, 2022 and 2032
Figure 62: Asia Pacific Market Attractiveness, by Country, 2022 to 2032
Figure 63: Asia Pacific Market Value Share, by Treatment Type, 2022 and 2032
Figure 64: Asia Pacific Market Attractiveness, by Treatment Type, 2022 to 2032
Figure 65: Asia Pacific Market Value Share, by Drug Type, 2022 and 2032
Figure 66: Asia Pacific Market Attractiveness Analysis, by Drug Type, 2022 to 2032
Figure 67: Asia Pacific Market Value Share, by Treatment Centers, 2022 and 2032
Figure 68: Asia Pacific Market Attractiveness Analysis, by Treatment Centers, 2022 to 2032
Figure 69: Asia Pacific Market Value Share, by Distribution Channels, 2022 and 2032
Figure 70: Asia Pacific Market Attractiveness Analysis, by Distribution Channels, 2022 to 2032
Figure 71: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022 to 2032
Figure 72: Latin America Market Value Share, by Country, 2022 and 2032
Figure 73: Latin America Market Attractiveness, by Country, 2022 to 2032
Figure 74: Latin America Market Value Share, by Treatment Type, 2022 and 2032
Figure 75: Latin America Market Attractiveness, by Treatment Type, 2022 to 2032
Figure 76: Latin America Market Value Share, by Drug Type, 2022 and 2032
Figure 77: Latin America Market Attractiveness Analysis, by Drug Type, 2022 to 2032
Figure 78: Latin America Market Value Share, by Treatment Centers, 2022 and 2032
Figure 79: Latin America Market Attractiveness Analysis, by Treatment Centers, 2022 to 2032
Figure 80: Latin America Market Value Share, by Distribution Channels, 2022 and 2032
Figure 81: Latin America Market Attractiveness Analysis, by Distribution Channels, 2022 to 2032
Figure 82: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2022 to 2032
Figure 83: Middle East & Africa Market Value Share, by Country, 2022 and 2032
Figure 84: Middle East & Africa Market Attractiveness, by Country, 2022 to 2032
Figure 85: Middle East & Africa Market Value Share, by Treatment Type, 2022 and 2032
Figure 86: Middle East & Africa Market Attractiveness, by Treatment Type, 2022 to 2032
Figure 87: Middle East & Africa Market Value Share, by Drug Type, 2022 and 2032
Figure 88: Middle East & Africa Market Attractiveness Analysis, by Drug Type, 2022 to 2032
Figure 89: Middle East & Africa Market Value Share, by Treatment Centers, 2022 and 2032
Figure 90: Middle East & Africa Market Attractiveness Analysis, by Treatment Centers, 2022 to 2032
Figure 91: Middle East & Africa Market Value Share, by Distribution Channels, 2022 and 2032
Figure 92: Middle East & Africa Market Attractiveness Analysis, by Distribution Channels, 2022 to 2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the estimated growth rate for addiction treatment market?
The global addiction treatment market is set to expand at a CAGR of 6.7% during the forecast period.
Which treatment type contributes to the growth of addiction treatment market?
The rising prevalence of cigarette smoking boosts the prospects for the tobacco and nicotine addiction treatment market.
Which is the leading regional market for addiction treatment?
North America is the most attractive region for the expansion of the addiction treatment market.
What is the key growth strategy of addiction treatment market players?
Production of de-addiction drugs and other formulae to assist patients remains the key growth strategy of the market players.
Addiction Treatment Market